2012
DOI: 10.1016/j.meegid.2012.03.017
|View full text |Cite
|
Sign up to set email alerts
|

Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil

Abstract: Leishmania braziliensis causes cutaneous (CL) and mucosal (ML) leishmaniasis. In the mouse, Fli1 was identified as a gene influencing enhanced wound healing and resistance to CL caused by L. major. Polymorphism at FLI1 is associated with CL caused by L. braziliensis in humans, with an inverse association observed for ML disease. Here we extend the analysis to look at other wound healing genes, including CTGF, TGFB1, TGFBR1/2, SMADS 2/3/4/7 and FLII, all functionally linked along with FLI1 in the TGF beta pathw… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
30
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 33 publications
(35 citation statements)
references
References 39 publications
4
30
1
Order By: Relevance
“…The COL1A1 FBAT analysis for the ML clinical phenotype, and leishmaniasis per se (CL+ML disease) in the primary (Families 101–168), replication (Families 169–325) and combined data set are presented in Supplementary Tables 1 and 2, respectively. Of interest, a trend for association (nominal P =0.079) between rs2586488 and ML disease in the replication families (Supplementary Table 1) showed the minor allele as the risk allele, whereas for CL disease (Table 1) the major allele was the risk allele, reminiscent of earlier findings with other wound healing genes (Castellucci et al, 2012; Castellucci et al, 2011). This contributed to reduction in the strength of associations seen at both rs1061237 and rs2586488 in the analysis of CL+ML as leishmaniasis per se (Supplementary Table 2).…”
Section: Resultssupporting
confidence: 54%
See 2 more Smart Citations
“…The COL1A1 FBAT analysis for the ML clinical phenotype, and leishmaniasis per se (CL+ML disease) in the primary (Families 101–168), replication (Families 169–325) and combined data set are presented in Supplementary Tables 1 and 2, respectively. Of interest, a trend for association (nominal P =0.079) between rs2586488 and ML disease in the replication families (Supplementary Table 1) showed the minor allele as the risk allele, whereas for CL disease (Table 1) the major allele was the risk allele, reminiscent of earlier findings with other wound healing genes (Castellucci et al, 2012; Castellucci et al, 2011). This contributed to reduction in the strength of associations seen at both rs1061237 and rs2586488 in the analysis of CL+ML as leishmaniasis per se (Supplementary Table 2).…”
Section: Resultssupporting
confidence: 54%
“…Sample collections made during two different time periods, 2000–2004 and 2008–2010, were well-matched geographically (Castellucci et al, 2012) and demographically (Table 1). Table 2 provides details of SNPs genotyped, and demonstrates that all SNPs were at a MAF ≥0.25 in this Brazilian population.…”
Section: Resultsmentioning
confidence: 96%
See 1 more Smart Citation
“…Further functional studies will be required to determine the possible role of LTBP4 in contributing to TGF-β regulation of VL pathogenesis. Our findings are also consistent with our prior reports of association between cutaneous leishmaniasis and genes in, or affecting, the TGF-β pathway (Castellucci et al, 2012; Castellucci et al, 2011), lending support to the broader importance of this pathway in pathogenesis of leishmaniasis.…”
Section: Discussionsupporting
confidence: 92%
“…FL1 is a transcription factor that represses CTGF (encoding connective tissue growth factor) expression via transforming growth factor-b signalling, thereby affecting collagen synthesis. Polymorphisms at loci involved in this pathway have been investigated, and significant results have been obtained for associations with CL at FL1, CTGF, TGFBR2, SMAD2, and SMAD7, and for associations with ML at SMAD3 and SMAD6 [44].…”
Section: Leishmaniasismentioning
confidence: 99%